OptiNose Inc (OPTN)
0.9087
+0.08
(+10.28%)
USD |
NASDAQ |
May 01, 16:00
0.9087
0.00 (0.00%)
After-Hours: 20:00
OptiNose Cash from Investing (TTM): -0.328M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.328M |
| September 30, 2023 | -0.258M |
| June 30, 2023 | -0.092M |
| March 31, 2023 | -0.015M |
| December 31, 2022 | -0.063M |
| September 30, 2022 | -0.084M |
| June 30, 2022 | -0.102M |
| March 31, 2022 | -0.019M |
| December 31, 2021 | -0.062M |
| September 30, 2021 | -0.124M |
| June 30, 2021 | -0.247M |
| March 31, 2021 | -0.567M |
| December 31, 2020 | -0.546M |
| Date | Value |
|---|---|
| September 30, 2020 | -0.532M |
| June 30, 2020 | -0.443M |
| March 31, 2020 | -0.459M |
| December 31, 2019 | -0.557M |
| September 30, 2019 | -0.725M |
| June 30, 2019 | -1.232M |
| March 31, 2019 | -1.476M |
| December 31, 2018 | -1.69M |
| September 30, 2018 | -2.646M |
| June 30, 2018 | -2.576M |
| March 31, 2018 | -2.698M |
| December 31, 2017 | -2.406M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.232M
Minimum
Jun 2019
-0.015M
Maximum
Mar 2023
-0.3397M
Average
-0.258M
Median
Sep 2023
Cash from Investing (TTM) Benchmarks
| Madrigal Pharmaceuticals Inc | -502.52M |
| Viking Therapeutics Inc | -641.08M |
| Zevra Therapeutics Inc | -17.39M |
| Spero Therapeutics Inc | 0.00 |
| Karuna Therapeutics Inc (DELISTED) | -160.32M |